The Column Group LLC
- SEC CIK
- 0001833486
- Latest filing
- Aug 14, 2026
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 12, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 7
- 0 vs. Q1 2022
- Portfolio value
- $469.9M
- −$69.5M (−12.9%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| NGMNGM Biopharmaceuticals Inc | COM | 18,136,735 | $232.5M | 49.5% | +1,890,918+11.6% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 4,395,050 | $85.7M | 18.2% | +1,047,805+31.3% | Added | History |
| TNYATenaya Therapeutics, Inc. | COM | 9,400,290 | $52.9M | 11.3% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 2,680,458 | $48.9M | 10.4% | +1,278,450+91.2% | Added | History |
| SRZNSurrozen, Inc. | COM | 9,248,129 | $27.7M | 5.9% | −166,666−1.8% | Reduced | History |
| ORICOric Pharmaceuticals, Inc. | COM | 3,568,181 | $16.0M | 3.4% | 00.0% | Unchanged | History |
| EFTReFFECTOR Therapeutics, Inc. | COM | 4,309,329 | $6.12M | 1.3% | 00.0% | Unchanged | History |